Pediatric Cancer Clinical Trials in Seattle, Washington

4 studies are recruiting for pediatric cancer in Seattle, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

    This study will evaluate BCB-276, an investigational B7-H3-targeted Chimeric Antigen Receptor (CAR) T cell therapy, in children and young adults with diffuse intrinsic pontine glioma (DIPG). DIPG is a rare and aggressive brain tumor with limited treatment options. CAR T cell therapy uses a patient'…

    Stage
    Phase 2
    Ages
    1 to 26
    Site
    Seattle Children's Hospital, Seattle, Washington
    Locations
    6 in total
    Run by
    BrainChild Bio, Inc

    See if you can join NCT07680439 on ClinicalTrials.gov

  2. Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

    Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

    Stage
    Phase 2
    Ages
    2 to 25
    Site
    Seattle Children's Hospital, Seattle, Washington
    Locations
    5 in total
    Run by
    Children's Hospital of Philadelphia

    See if you can join NCT06458036 on ClinicalTrials.gov

  3. Targeted Therapy to Increase RAI Uptake in Metastatic DTC

    Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently targeted drugs that block many of the genetic drivers of DTC have become available. While Investigators know that these dru…

    Stage
    Not phased
    Ages
    0 and older
    Site
    Seattle Children's Hospital, Seattle, Washington
    Locations
    9 in total
    Run by
    Children's Hospital of Philadelphia

    See if you can join NCT05024929 on ClinicalTrials.gov

  4. Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

    Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

    Stage
    Phase 2
    Ages
    2 to 99
    Site
    Seattle Children's Hospital, Seattle, Washington
    Locations
    5 in total
    Run by
    Children's Hospital of Philadelphia

    See if you can join NCT05783323 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.